register

Medical

Private oncologists welcome subsidised telehealth for vulnerable patients

Health Industry Hub | March 18, 2020 |

The nation’s peak body of cancer doctors has applauded the Morrison Government for its swift and unprecedented move to offer bulkbilled telehealth appointments for certain groups of vulnerable Australians.

The Private Cancer Physicians of Australia (PCPA) said the pace in which the Government has moved to apply Medicare Benefits Schedule (MBS) items to telehealth GP and specialist appointments for patients, most at risk of the COVID-19 virus (or those self-isolating), was unprecedented.

“Like any patient with an underlying chronic health issues, cancer patients are particularly vulnerable during this pandemic,” said the President of the PCPA, Dr Christopher Steer. 

“Our patients are regular attendees at their GP clinics and out-patient clinics, which are now being frequented with those who have the COVID-19 virus.

“If cancer patients, many of whom will have a compromised immunity, can be provided with medical advice and support, over the phone or via a videoconference, rather than sitting in a doctors’ waiting room, then that is a significantly safer option for them,” Dr Steer said.

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

The measure MBS Telehealth, was announced by the Morrison Government last week.

This is a temporary six-month measure. Should the Australian Health Protection Principal Committee (AHPPC) recommend an extension, it will be considered by the Government.

“Being diagnosed with cancer and having treatment is stressful as it is,” said Dr Steer. “Knowing you can now access a bulk billed appointment with your doctor, from the safety of your own home, is a very welcomed development and one we hope may continue past this pandemic.”

HCP engagement in COVID-19 times – Keep your people safe and maximise HCP reach and engagement digitally. Learn more about how we can help your team – solutions developed by industry for industry.


News & Trends - MedTech & Diagnostics

Medtech, academia and government unite: Breaking down silos to deliver the power and promise of digital health to patients

Health Industry Hub | December 11, 2023 |

MedTech & Diagnostics News: In an interview with Health Industry Hub, Annette Schmiede, CEO of Digital Health Cooperative Research Centre […]

More


News & Trends - MedTech & Diagnostics

Two-decade evolution of robotic surgery in Australia's medical landscape

Two-decade evolution of robotic surgery in Australia’s medical landscape

Health Industry Hub | December 11, 2023 |

MedTech & Diagnostics News: In the past two decades, what was once deemed impossible in surgery has now become a […]

More


News & Trends - Pharmaceuticals

World-first in IVF: Merging AI and genomics to optimise treatment response

World-first in IVF: Merging AI and genomics to optimise treatment response for Australians

Health Industry Hub | December 11, 2023 |

Pharma News: A world-first Australian IVF study exploring genome sequencing has garnered enthusiastic reception from its collaborative research partners. Securing […]

More


News & Trends - Pharmaceuticals

PBS listing marks first oral therapy for childhood arthritis

PBS listing marks first oral therapy for childhood arthritis

Health Industry Hub | December 11, 2023 |

Pharma News: The first oral Janus kinase (JAK) inhibitor, Pfizer’s Xeljanz (tofacitinib), has been listed on the Pharmaceutical Benefits Scheme […]

More


This content is copyright protected. Please subscribe to gain access.